Title
Amending Section 9-637 of The Philadelphia Code, entitled “Opioid Antidote Availability,” to revise certain provisions relating to the form of naloxone available and technical changes to the penalties for not complying with provisions of this law, all under certain terms and conditions.
Body
THE COUNCIL OF THE CITY OF PHILADELPHIA HEREBY ORDAINS:
SECTION 1. Chapter 9-600 is hereby amended to read as follows:
CHAPTER 9-600 SERVICE AND OTHER BUSINESSES
***
§9-637. Opioid Antidote Availability
***
(2) Opioid Antidote Stocking Requirement. Retail Pharmacies shall maintain a pharmaceutical stock sufficient to fill at least two (2) requests for Opioid Antidotes made pursuant to Pennsylvania Department of Health Standing Order DOH-001-2018, “Naloxone Prescription for Overdose Prevention,” another applicable standing order for Opioid Antidotes, or an individual prescription for a single-use dose of an Opioid Antidote.
(a) The following shall in any case constitute a sufficient stock of Opioid Antidotes for purposes of this subsection (2): two (2) NARCANä nasal spray, or any other form of naloxone, cartons containing two blister packages each with single 4 mg dose of naloxone in a 0.1 mL intranasal spray.
(b) It shall be an affirmative defense to this subsection (2) to demonstrate either:
***
(.3) A pharmacy, upon request, provides proof of purchase that an order for NARCANä, or any other form of naloxone, has been placed and is awaiting delivery to a given pharmacy.
SECTION 2. This Ordinance shall take effect immediately.
___________________________________
Explanation:
[Brackets] indicate matter deleted.
Italics indicate new matter added.
End